Your browser doesn't support javascript.
loading
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Murthy, Hemant S; Ahn, Kwang Woo; Estrada-Merly, Noel; Alkhateeb, Hassan B; Bal, Susan; Kharfan-Dabaja, Mohamed A; Dholaria, Bhagirathbhai; Foss, Francine; Gowda, Lohith; Jagadeesh, Deepa; Sauter, Craig; Abid, Muhammad Bilal; Aljurf, Mahmoud; Awan, Farrukh T; Bacher, Ulrike; Badawy, Sherif M; Battiwalla, Minoo; Bredeson, Chris; Cerny, Jan; Chhabra, Saurabh; Deol, Abhinav; Diaz, Miguel Angel; Farhadfar, Nosha; Freytes, César; Gajewski, James; Gandhi, Manish J; Ganguly, Siddhartha; Grunwald, Michael R; Halter, Joerg; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Inamoto, Yoshihiro; Jimenez-Jimenez, Antonio Martin; Kalaycio, Matt; Kamble, Rammurti; Krem, Maxwell M; Lazarus, Hillard M; Lazaryan, Aleksandr; Maakaron, Joseph; Munshi, Pashna N; Munker, Reinhold; Nazha, Aziz; Nishihori, Taiga; Oluwole, Olalekan O; Ortí, Guillermo; Pan, Dorothy C; Patel, Sagar S; Pawarode, Attaphol; Rizzieri, David; Saba, Nakhle S.
Affiliation
  • Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address: Murthy.Hemant@Mayo.edu.
  • Ahn KW; Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Estrada-Merly N; Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Alkhateeb HB; Division of hematology and Bone Marrow Transplantation, Mayo Clinic, Rochester, Minnesora.
  • Bal S; Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Dholaria B; Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Foss F; Division of Hematology Oncology, Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.
  • Gowda L; Division of Hematology Oncology, Yale Cancer Center and Yale School of Medicine, New Haven, Connecticut.
  • Jagadeesh D; Department of Hematology and Medical Oncology, Taussig Cancer Institue, Cleveland Clinic, Cleveland, Ohio.
  • Sauter C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Abid MB; Divisions of Hematology/Oncology and Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Awan FT; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Badawy SM; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Battiwalla M; Sarah Cannon Blood Cancer Network, Nashville, Tennessee.
  • Bredeson C; The Ottawa Hospital Transplant & Cellular Therapy Program, Ottawa, Ontario, Canada.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
  • Chhabra S; Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Deol A; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
  • Freytes C; University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Gajewski J; Consultant, Lu Daopei Hospital, Beijing, China.
  • Gandhi MJ; Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Halter J; University Hospital of Basel, Basel, Switzerland.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Jimenez-Jimenez AM; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, Florida.
  • Kalaycio M; Department of Hematology and Medical Oncology, Taussig Cancer Institue, Cleveland Clinic, Cleveland, Ohio.
  • Kamble R; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Krem MM; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Lazarus HM; Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Lazaryan A; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Maakaron J; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Munshi PN; Stem Cell Transplant and Cellular Immunotherapy Program, MedStar Georgetown University Hospital, Washington, District of Columbia.
  • Munker R; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Nazha A; Department of Hematology and Medical Oncology, Taussig Cancer Institue, Cleveland Clinic, Cleveland, Ohio.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Oluwole OO; Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ortí G; Hematology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Pan DC; Division of Hematology and Oncology, SUNY Upstate Medical University Hospital, Syracuse, New York.
  • Patel SS; Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Saba NS; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana.
Transplant Cell Ther ; 28(4): 187.e1-187.e10, 2022 04.
Article in En | MEDLINE | ID: mdl-35081472
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Prolymphocytic, T-Cell / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Prognostic_studies Limits: Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Prolymphocytic, T-Cell / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Prognostic_studies Limits: Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication: